Michael G Sarr

Dr. Michael G Sarr


Research Focus & Metrics

Academic Career Length

32Years (1995-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2003 in Journal of Gastrointestinal Surgery
Verified
Journal Article
Closed access
MSMichael G Sarr
Michael G Sarr
MMMichel Murr
Michel Murr
TSThomas C Smyrk
Thomas C Smyrk
CYCharles J Yeo
Charles J Yeo
CFCarlos Fernandez-Del-Castillo
Carlos Fernandez-Del-Castillo
PFPatrick C Freeny
Patrick C Freeny

1 January 2009 in Pancreatology
Verified
Journal Article
Closed access
TGTimothy B. Gardner
Timothy B. Gardner
SVSanthi Swaroop Vege
Santhi Swaroop Vege
SCSuresh T. Chari
Suresh T. Chari
BPBret T. Petersen
Bret T. Petersen
MTMark D. Topazian
Mark D. Topazian
MSMichael G Sarr
Michael G Sarr
We evaluated the impact of the initial intravenous fluid resuscitation rate within the first 24 h of presentation to the emergency room on important outcomes in severe acute pancreatitis. Patients presenting directly with a diagnosis of severe acute pancreatitis were identified retrospectively. Patients were divided into two groups - those who received >or=33% ('early resuscitation') and <33% ('late resuscitation') of their cumulative 72-hour intravenous fluid volume within the first 24 h of presentation. The primary clinical outcomes were in-hospital mortality, development of persistent organ failure, and duration of hospitalization. 17 patients were identified in the 'early resuscitation' group and 28 in the 'late resuscitation' group and there were no baseline differences in clinical characteristics between groups. Patients in the 'late resuscitation' group experienced greater mortality than those in the 'early resuscitation' group (18 vs. 0%, p < 0.04) and demonstrated a trend toward greater rates of persistent organ failure (43 vs. 35%, p = 0.31). There was no difference in the total amount of fluid given during the first 72 h. Patients with severe acute pancreatitis who do not receive at least one third of their initial 72-hour cumulative intravenous fluid volume during the first 24 h are at risk for greater mortality than those who are initially resuscitated more aggressively.

22 October 2007 in World Journal of Surgery
Verified
Journal Article
Closed access
PDF file
CICorey W. Iqbal
Corey W. Iqbal
TPTuan H. Pham
Tuan H. Pham
AJAnthony Joseph
Anthony Joseph
JMJane Mai
Jane Mai
GTGeoffrey B. Thompson
Geoffrey B. Thompson
MSMichael G Sarr
Michael G Sarr

8 September 2012 in Obesity Surgery
Verified
Journal Article
Closed access
PDF file
TGThe EMPOWER Study Group
The EMPOWER Study Group
MSMichael G Sarr
Michael G Sarr
CBCharles J. Billington
Charles J. Billington
RBRoy Brancatisano
Roy Brancatisano
ABAnthony Brancatisano
Anthony Brancatisano
RRRaul Rosenthal
Raul Rosenthal

25 January 2013 in Polish Archives of Internal Medicine
Verified
Journal Article
Open access
MSMichael G Sarr
Michael G Sarr
Recently, the original Atlanta classification of 1992 was revised and updated by the Working Group using a web-based consultative process involving multiple international pancreatic societies. The new understanding of the disease, its natural history, and objective description and classification of pancreatic and peripancreatic fluid collections make this new 2012 classification a potentially valuable means of international communication and interest. This revised classification identifies 2 phases of acute pancreatitis - early (first 1 or 2 weeks) and late (thereafter). Acute pancreatitis can be either edematous interstitial pancreatitis or necrotizing pancreatitis, the latter involving necrosis of the pancreatic parenchyma and peripancreatic tissues (most common), pancreatic parenchyma alone (least common), or just the peripancreatic tissues (~20%). Severity of the disease is categorized into 3 levels: mild, moderately severe, and severe. Mild acute pancreatitis lacks both organ failure (as classified by the modified Marshal scoring system) and local or systemic complications. Moderately severe acute pancreatitis has transient organ failure (organ failure of <2 days), local complications, and/or exacerbation of coexistent disease. Severe acute pancreatitis is defined by the presence of persistent organ failure (organ failure that persists for ≥2 days). Local complications are defined by objective criteria based primarily on contrast-enhanced computed tomography; these local complications are classified as acute peripancreatic fluid collections, pseudocyst (which are very rare in acute pancreatitis), acute (pancreatic/peripancreatic) necrotic collection, and walled-off necrosis. This classification will help the clinician to predict the outcome of patients with acute pancreatitis and will allow comparison of patients and disease treatment/management across countries and practices.

1 January 2012 in Surgery
Verified
Journal Article
Closed access
YZYe Zheng
Ye Zheng
JSJeffrey S. Scow
Jeffrey S. Scow
JDJudith A. Duenes
Judith A. Duenes
MSMichael G Sarr
Michael G Sarr